Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK and Subjective Effects of High Dose Sublingual Nicotine vs Snus
NCT01838460Phase 2Completed
- Sponsor
- Contract Research Organization el AB
- Start
- May 2012
- Primary completion
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of nicotine in nicotine dependence (5 arms), sponsored by Contract Research Organization el AB. Primary endpoint: Area Under the Plasma Concentration-Time Curve from Time Zero to Infinity at 6 hours. Started May 2012; status: completed.
02
Drugs
nicotine
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT01838460.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01838460.